2-Year U.S. Treasury Note Continuous Contract $101.527 0.047 0.05% 5-Year U.S. Treasury Note Continuous Contract $105.141 0.195 0.19% 10-Year U.S. Treasury Note Continuous Contract $108.078 0.375 ...
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, discovers and develops tumor-activated immuno-oncology therapies. Its checkpoint inhibitor program includes XTX101, an ...